
Jonathon Kellerman has joined Ireland-based speciality pharma firm Actavis as its executive vice president and global chief compliance officer. Reporting …
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour

